Next Article in Journal
Investigating the Formation of Structural Elements in Proteins Using Local Sequence-Dependent Information and a Heuristic Search Algorithm
Next Article in Special Issue
Alkene Difunctionalization Using Hypervalent Iodine Reagents: Progress and Developments in the Past Ten Years
Previous Article in Journal
Sulfide (Na2S) and Polysulfide (Na2S2) Interacting with Doxycycline Produce/Scavenge Superoxide and Hydroxyl Radicals and Induce/Inhibit DNA Cleavage
Previous Article in Special Issue
Sulfonylimino Group Transfer Reaction Using Imino-λ3-iodanes with I2 as Catalyst Under Metal-free Conditions
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 24
Issue 6
10.3390/molecules24061147
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Cu-Catalyzed Oxidative 3-Amination of Indoles via Formation of Indolyl(aryl)iodonium Imides Using o-Substituted (Diacetoxyiodo)arene as a High-Performance Hypervalent Iodine Compound

by
Kazuhiro Watanabe
and
Katsuhiko Moriyama
*
Department of Chemistry, Graduate School of Science, and Molecular Chirality Research Center, Chiba University, 1-33 Yayoi-cho, Inage-ku, Chiba 263-8522, Japan
*
Author to whom correspondence should be addressed.
Molecules 2019, 24(6), 1147; https://0-doi-org.brum.beds.ac.uk/10.3390/molecules24061147
Submission received: 27 February 2019 / Revised: 14 March 2019 / Accepted: 21 March 2019 / Published: 22 March 2019
(This article belongs to the Special Issue Advances in the Chemistry of Hypervalent Iodine Compounds)
Browse Figures
Review Reports Versions Notes

Abstract

:
An oxidative 3-amination of indole derivatives using hypervalent iodine(III) and bissulfonimides, which proceeds via the formation of indolyl(aryl)iodonium imides, was developed. This reaction was followed by an indole-selective copper-catalyzed oxidative C–N coupling reaction to obtain 3-amino indole derivatives as single regioisomers. o-Alkoxy(diacetoxyiodo)arenes showed higher reactivity in the reaction than o-alkyl(diacetoxyiodo)arenes, efficiently promoting the formation of indolyl(aryl)iodonium imides in the first step.

Graphical Abstract

1. Introduction

The direct installation of an amino group into an indole skeleton is a very important strategy to generate amino indole derivatives, which are key building blocks for indole-based natural products and biologically active compounds [1,2,3,4,5,6]. The novel 3-selective amination of indole derivatives has attracted considerable attention from synthetic organic chemists. Regarding previous work on the 3-selective amination of indole derivatives, the nitration of protecting-group-free and N-protected indoles with metal nitrate or nitric acid is well known (Scheme 1A) [7,8,9,10,11,12]. Sudalai and coworkers reported an azidation of indole derivatives with a stoichiometric amount of I2 and NaN3 to give 3-azide indole derivatives (Scheme 1B) [13]. Wang and coworkers developed an electrophilic amidation of indoles with N-[(benzenesulfonyl)oxy]amide as the electrophilic nitrogen agent in the presence of ZnCl2 (Scheme 1C) [14]. As examples of the C–N coupling reaction of indoles with a nucleophilic nitrogen source, the azidation with NaN3 via the formation of indolyl(phenyl)iodonium azide (Scheme 1D) [15], and the amination of alkylamines via the formation of indolyl(Mes)iodonium tosylate (Scheme 1E) [16] from electron-donating group protected 2-substituted indoles using hypervalent iodine compounds were developed by Suna and coworkers. Regarding the 3-amination of electron-withdrawing group protected indoles, the 3-imidation of N-acetyl indoles with (PhSO2)2NF under transition-metal-free conditions was developed by Yang and coworkers (Scheme 1F) [17].
On the other hand, we were able to prepare indolyl(aryl)iodonium imides, which are related to I–N bonding hypervalent iodine compounds, from N-electron-withdrawing group protected indoles, bissulfonimides, and (diacetoxyiodo)arenes [18,19], and to achieve the dual functionalization of indoles via halo-amination with halogen reagents using the indolyl(aryl)iodonium imides [18,20].
We report herein a 3-selective C–N coupling reaction of N-electron-withdrawing group protected indoles with various bissulfonimides using hypervalent iodine compounds (Scheme 1G). In our previous work, the indole-selective C–N coupling reaction of indolyl(aryl)iodonium imides promoted by a copper catalyst gave 3-amino indole derivatives [21]. Furthermore, in the copper-catalyzed C–N coupling reaction, indolyl(2-butoxyphenyl)iodonium bistosylimide showed high indole selectivity whereas indolyl(phenyl)iodonium bistosylimide showed aryl selectivity (Scheme 2). From the results, we envisioned that (diacetoxy)iodoarene bearing an o-substituted phenyl group would promote the copper-catalyzed C–N coupling reaction of indoles with bissulfonimides via the formation of indolyl(aryl)iodonium imides. To obtain the corresponding 3-amino indole derivatives using this method, the formation of indolyl(aryl)iodonium imides should proceed effectively other than indole selectivity in the C–N coupling reaction of indolyl(aryl)iodonium imides. However, it is possible that steric hindrance by o-substituted bissulfonimidoiodoarene (ArI(OAc)(N(SO2R2)2) or ArI(N(SO2R2)2)2), which is generated in situ from the reaction of (diacetoxyiodo)arene with bissulfonimides, would suppress the formation of indolyl(aryl)iodonium imides. The necessity of appropriate steric hindrance and the electronic effect of o-alkoxy group substituted iodoarene moiety on hypervalent iodine(III) compounds in the 3-amination of N-electron-withdrawing group protected indoles were evaluated on the basis of comparisons with other o-substituted (diacetoxyiodo)arenes.

2. Results and Discussion

First, we conducted screening for (acetoxy)iodoarene, copper catalyst, and solvent for the 3-amination of indoles on the basis of previously reported reaction conditions (Table 1). It is important to use MeCN as a solvent in the formation of indolyl(aryl)iodonium imides (in the first step) and toluene-related solvent (i.e., toluene and xylene) in the copper-catalyzed C–N coupling reaction (in the second step) to progress each reaction efficiently [18,20,21]. Treatment of N-pivaloyl indole (1a) with Ts2NH (1.6 equiv.) and PhI(OAc)2 (1.2 equiv.) in MeCN at 40 °C for 7 h, followed by the addition of Cu(MeCN)4BF4 (5 mol%) in toluene under reflux conditions for 1 h provided N-pivaloyl-3-bistosylimido indole (2a) in 26% yield together with N,N-bistosylaniline in 58% yield as a byproduct (Entry 1). When (diacetoxyiodo)2-butoxybenzene (A), (diacetoxyiodo)2,4,6-trimethylbenzene (B), and (diacetoxyiodo)2,6-dimethoxybenzene (D) were used instead of PhI(OAc)2, the C–N coupling reaction showed high indole selectivity to obtain the desired product (2a) in high yields (76–82% yield) (Entries 2, 3, and 5). The use of (diacetoxyiodo)2,4,6-triisopropylbenzene (C) and 1-acetoxy-1,2-benziodoxol-3-(1H)-one (E) gave 2a in moderate to low yields (Entries 4 and 6). (Diacetoxyiodo)arenes (A, B, and D) as o-substituted hypervalent iodine compounds were adopted for use in xylene at 130 °C for the 3-amination of indoles, and similar reactivity to that in toluene under reflux conditions was realized (Entries 7–9). By contrast, the reaction with (diacetoxyiodo)arenes A, B, and D in the absence of copper catalyst gave 2a in low yields (16–42% yield) (Entries 10–12).
Then, (diacetoxyiodo)arenes A, B, and D were utilized in the reaction with N-pivaloyl 5-chloroindole (1b) under two conditions (in toluene under reflux conditions and in xylene at 130 °C) to clarify substrate generality for the 3-amination of indoles (Scheme 3). Treatment of 1b with (diacetoxyiodo)2-butoxybenzene (A) in xylene at 130 °C in the second step provided the desired product (2b) in 75% yield. However, when (diacetoxyiodo)2,4,6-trimethylbenzene (B) was used under similar conditions to those in the reaction with A, the reactivity of B with 1b declined to give 2b in 48% yield. (Diacetoxyiodo)2,6-dimethoxybenzene (D) showed similar reactivity to A (68% yield). It is noteworthy that the reaction of 1b in toluene under reflux conditions in the second step using the three (diacetoxyiodo)arenes (A, B, and D) generated small quantities of 2-aminated indole derivative as byproduct (5–9% yield). Therefore, we determined that the reaction in xylene at 130 °C in the presence of Cu(MeCN)4BF4 catalyst was the best option for the second step in the 3-amination of indoles using (diacetoxyiodo)arenes.
To compare the reactivities of (diacetoxyiodo)arenes (A, B, and D) in the copper-catalyzed 3-amination of indoles, N-protected indoles (1) were examined under optimum conditions (Scheme 4). Treatment of N-pivaloyl indole (1a) with various bissulfonimides, containing an aromatic group, an aliphatic group, or a dissymmetric functional group provided corresponding 3-amino indole derivatives (2c–f) in 51–81% yields, respectively. Unfortunately, the reaction with Ms2NH gave N-pivaloyl-2-dimesylimido-indole derivative (3f) in 10–14% yields as the by-product. The reaction of 5- and 6-substituted indoles bearing an alkyl group (1g and 1o), a halogen (1h, 1i, and 1p–r), an ether (1j and 1s), an ester (1k and 1l), and a phthalimide (1n) also produced corresponding products (2g–l, 2n–s) in 39–84% yields, respectively. Use of 7-substituted indole (1u) and 2-substituted indole (1w) derivatives in the present reaction also furnished the desired products (2u and 2w) in good yields (60–76%). Other indole protecting groups, such as benzoyl (1x) and tosyl (1y) groups, instead of a pivaloyl group also enhanced the reactivities of (diacetoxyiodo)arenes in the present reaction to give 3-amino indole derivatives (2x and 2y) in high yields (72–91%). In the reaction of 5-cyano (1m), 4-fluoro (1t), and 5,6-dichloro indole (1v) derivatives, (diacetoxyiodo)2-butoxybenzene (A) or (diacetoxyiodo)2,6-dimethoxybenzene (D) improved the yields of 3-amino indole derivatives (2m, 2t, and 2v) to 50–59% yield, whereas other (diacetoxyiodo)arenes showed low reactivity (20–36% yield). It is noteworthy that (diacetoxyiodo)arenes A and D are superior to (diacetoxyiodo)2,4,6-trimethylbenzene (B) in the one-pot 3-amination of indoles.
Furthermore, we examined the reaction of N-pivaloyl-5-chloroindole (1b) with Ts2NH and (diacetoxyiodo)arene (A, B, and D) in MeCN at 40 °C, which forms indolyl(aryl)iodonium imide (4b) (in the first step), to elucidate the reason why the reactivities of (diacetoxyiodo)arenes differ in the 3-amination of indole derivatives (Scheme 5). When (diacetoxyiodo)2-butoxybenzene (A) and (diacetoxyiodo)2,6-dimethoxybenzene (D) were used in this reaction, indolyl(aryl)iodonium imide (4b) was obtained in good yields (54% and 65%) together with 3-amino indole derivative (2b) (14% and 19%) and 2-amino indole derivative (3b) (12% and 13%). In contrast, (diacetoxyiodo)2,4,6-trimethylbenzene (B) showed lower reactivity than ArI(OAc)2 A and D (25% yield of 4b and 15% recovery of 1b). From the results, we suggest that the difference in reactivity among the (diacetoxyiodo)arenes in the 3-amination of indoles is strongly dependent on the reactivity in the formation of indolyl(aryl)iodonium imide in the first step.
In addition, it is possible that 3b is converted into 2b via rearrangement by a copper catalyst, based on the results that 3b was not generated in xylene at 130 °C, but was obtained in toluene under reflux conditions (Scheme 3). The reaction of N-pivaloyl 2-bistosylimido-5-chloroindole (3b) in the presence of Cu(MeCN)4BF4 catalyst in xylene at 130 °C provided a complex mixture without the formation of 2b (Scheme 6).
Based on the results of mechanistic studies, we propose a reaction mechanism for the 3-amination of indole derivatives, as shown in Scheme 7. The reaction of indole derivatives (1) with (diacetoxyiodo)arenes (ArI(OAc)2) and bissulfonimides ((R2SO2)2NH) in MeCN, which generates (sulfonimidoiodo) arene intermediates (ArI(OAc)(N(SO2R2)2) or ArI (N(SO2R2)2)2) in situ, provides indolyl(aryl)iodonium imides (4) together with 3-amino indole derivatives (2) and 2-amino indole derivatives (3) in the first step. The alkoxy groups at o-positions of iodoarenes result in higher reactivity than the alkyl groups to induce the formation of amino group-containing products. Subsequently, indolyl(aryl)iodonium imides (4) are converted into 3-amino indole derivatives (2) through an oxidative C–N coupling reaction using Cu(MeCN)4BF4 catalyst [21]. It is noteworthy that the o-substituent on iodoarene is essential to prompt the indole selectivity for the C–N coupling reaction of 4. In contrast, 2-amino indole derivatives (3) are decomposed in the presence of a copper catalyst under heating conditions.

3. Materials and Methods

3.1. General Procedure

1H NMR spectra were measured on a JEOL ECS-500 (500 MHz) spectrometer at ambient temperature. Data were recorded as follows: chemical shift in ppm from internal tetramethylsilane on the δ scale, multiplicity (s = singlet; d = doublet; t = triplet; q = quartet; sep = septet; m = multiplet; br = broad), coupling constant (Hz), integration, and assignment. 13C NMR spectra were measured on a JEOL ECS-500 (125 MHz) spectrometer (see Supplementary Materials). Chemical shifts were recorded in ppm from the solvent resonance employed as the internal standard (deuterochloroform at 77.0 ppm). High-resolution mass spectra were recorded by Thermo Fisher Scientific Exactive Orbitrap mass spectrometers. Infrared (IR) spectra were recorded on a JASCO FT/IR 4100 spectrometer. Single crystal X-ray diffraction data were collected at 173K on a Bruker SMART APEX II ultra CCD diffractometer with Cu Kα (λ = 1.54178) radiation and graphite monochromator. For thin-layer chromatography (TLC) analysis throughout this work, Merck precoated TLC plates (silica gel 60GF254 0.25 mm) were used. The products were purified by neutral column chromatography on silica gel (Kanto Chemical Co., Inc. silica gel 60N, Prod. No. 37560-84; Merck silica gel 60, Prod. No. 1.09385.9929). Visualization was accomplished by UV light (254 nm), anisaldehyde, KMnO4, and phosphomolybdic acid. In experiments that required dry solvents such as MeCN, toluene, and xylene (mixed isomers), these were distilled in prior to use.

3.2. General Procedure for 3-Amination of Indoles 1

A mixture of 1-(diacetoxyiodo)-2-butoxybenzene (94.6 mg, 0.24 mmol) and Ts2NH (104.1 mg, 0.32 mmol) in MeCN (2.0 mL) was stirred at room temperature for 30 min under argon atmosphere. Then, N-pivaloylindole (1a) (40.3 mg, 0.20 mmol) was added, and the solution was stirred at 40 °C for 7 h under argon atmosphere. The reaction mixture was concentrated under reduced pressure and the crude product was dissolved xylene (mixed isomers) (2.0 mL). Cu(MeCN)4BF4 (3.1 mg, 0.01 mmol) was added to the reaction mixture at room temperature, and further stirred at 130 °C for 1 h under argon atmosphere. Saturated NaHCO3 aqueous solution (10 mL) was added to the reaction mixture, and the product was extracted with AcOEt (15 mL × 3). The combined extracts were washed with brine (10 mL) and dried over Na2SO4. The organic phase was concentrated under reduced pressure and the crude product was purified by silica gel column chromatography (eluent: hexane/AcOEt = 5/1), to give the desired product 2a (82.3 mg, 78% yield).
4-Methyl-N-(1-pivaloyl-1H-indol-3-yl)-N-tosylbenzenesulfonamide (2a). White solid, mp 214.0–214.5 °C, 1H NMR (500 MHz, CDCl3) δ 1.40 (s, 9H), 2.46 (s, 6H), 7.07 (d, J = 7.8 Hz, 1H), 7.14–7.19 (m, 1H), 7.30–7.37 (m, 1H), 7.32 (d, J = 8.2 Hz, 4H), 7.46 (s, 1H), 7.87 (d, J = 8.2 Hz, 4H), 8.46 (d, J = 8.3 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 21.7 (2C), 28.5 (3C), 41.3, 115.8, 117.3, 118.6, 124.1, 126.0, 126.8, 127.7, 128.6 (4C), 129.6 (4C), 135.7, 136.2 (2C), 145.2 (2C), 176.7. IR (neat) 1702, 1374, 1357, 1316, 1165 cm–1. MS (ESI) calcd for C27H29N2O5S2 [M + H]+ 525.1512, found 525.1501. Crystal data for 2a: Formula C27H28N2O5S2, colorless, crystal dimensions 0.30 × 0.20 × 0.20 mm3, Triclinic, space group P −1, a = 9.475(2) Å, b = 10.144(2) Å, c = 13.660(3) Å, α = 98.118(3) °, β = 91.348(3) °, γ = 100.871(3) °, V = 1274.7(5) Å3, Z = 2, ρcalc = 1.367 g cm−3, F(000) = 552, μ(MoKα) = 0.250 mm−1, T = 173 K. 7413 reflections collected, 5602 independent reflections with I > 2σ(I) (2θmax = 27.572°), and 330 parameters were used for the solution of the structure. The non-hydrogen atoms were refined anisotropically. R1 = 0.0508 and wR2 = 0.1031. GOF = 1.015. Crystallographic data (excluding structure factors) for the structure reported in this paper have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication no. CCDC-1860598. Copies of the data can be obtained free of charge on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK [Fax: int. code + 44(1223)336-033; E-mail: [email protected]].
N-(5-Chloro-1-pivaloyl-1H-indol-3-yl)-4-methyl-N-tosylbenzenesulfonamide (2b): White solid, mp 205.5–206.0 °C, 1H NMR (500 MHz, CDCl3) δ 1.41 (s, 9H), 2.48 (s, 6H), 6.81 (d, J = 2.0 Hz, 1H), 7.27 (d, J = 8.9, 2.0 Hz, 1H), 7.33 (d, J = 8.5 Hz, 4H), 7.52 (s, 1H), 7.85 (d, J = 8.5 Hz, 4H), 8.38 (d, J = 8.9 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 21.7 (2C), 28.4 (3C), 41.3, 115.2, 118.2, 118.4, 126.2, 128.0, 128.6 (4C), 128.7, 129.7 (4C), 130.0, 133.9, 136.0 (2C), 145.6 (2C), 176.6. IR (neat) 1708, 1379, 1351, 1307, 1163, 1085 cm–1. MS (ESI) calcd for C27H28ClN2O5S2 [M + H]+ 559.1123, found 559.1119.
N-(Phenylsulfonyl)-N-(1-pivaloyl-1H-indol-3-yl)benzenesulfonamide (2c). White solid, mp 182.0–183.0 °C, 1H NMR (500 MHz, CDCl3) δ 1.39 (s, 9H), 7.01 (d, J = 8.0 Hz, 1H), 7.12–7.18 (m, 1H), 7.31–7.37 (m, 1H), 7.48 (s, 1H), 7.50–7.56 (m, 4H), 7.67 (t, J = 7.5 Hz, 2H), 7.97–8.02 (m, 4H), 8.47 (d, J = 8.5 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 28.5 (3C), 41.3, 115.5, 117.3, 118.5, 124.2, 126.1, 126.6, 127.7, 128.5 (4C), 129.0 (4C), 134.1 (2C), 135.6, 139.0 (2C), 176.7. IR (neat) 1704, 1381, 1344, 1315, 1159 cm–1. MS (ESI) calcd for C25H25N2O5S2 [M + H]+ 497.1199, found 497.1205.
4-Methyl-N-(methylsulfonyl)-N-(1-pivaloyl-1H-indol-3-yl)benzenesulfonamide (2d). White solid, mp 221.5–22.0 °C, 1H NMR (500 MHz, CDCl3) δ 1.44 (s, 9H), 2.43 (s, 3H), 3.56 (s, 3H), 7.23–7.30 (m, 3H), 7.30–7.34 (m, 1H), 7.34–7.40 (m, 1H), 7.62 (s, 1H), 7.79 (d, J = 8.3 Hz, 2H), 8.48 (d, J = 8.3 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 21.7, 28.5 (3C), 41.4, 44.0, 115.2, 117.4, 118.2, 124.4, 126.2, 126.7, 127.2, 128.8 (2C), 129.6 (2C), 135.1, 135.7, 145.6, 176.7. IR (neat) 1704, 1366, 1349, 1317, 1157 cm–1. MS (ESI) calcd for C21H25N2O5S2 [M + H]+ 449.1199, found 449.1198.
N-(1-Pivaloyl-1H-indol-3-yl)-N-(propylsulfonyl)propane-1-sulfonamide (2e). White solid, mp 190.0–191.0 °C, 1H NMR (500 MHz, CDCl3, 60 °C) δ 1.07 (t, J = 7.3 Hz, 6H), 1.52 (s, 9H), 1.88–2.01 (m, 4H), 3.37–3.55 (m, 2H), 3.55–3.75 (m, 2H), 7.31–7.41 (m, 2H), 7.62 (d, J = 7.5 Hz, 1H), 7.88 (s, 1H), 8.50 (d, J = 8.0 Hz, 1H). 13C NMR (125 MHz, CDCl3, 60 °C) δ 12.8 (2C), 17.1 (2C), 28.7 (3C), 41.5, 57.7 (2C), 115.5, 117.6, 118.5, 124.5, 126.2, 126.9, 127.2, 135.9, 176.7. IR (neat) 1703, 1370, 1347, 1316, 1151 cm–1. MS (ESI) calcd for C19H29N2O5S2 [M + H]+ 429.1512, found 429.1512.
N-(Methylsulfonyl)-N-(1-pivaloyl-1H-indol-3-yl)methanesulfonamide (2f). White solid, mp 205.0–207.0 °C, 1H NMR (500 MHz, CDCl3) δ 1.54 (s, 9H), 3.44 (s, 6H), 7.35–7.40 (m, 1H), 7.40–7.45 (m, 1H), 7.58–7.63 (m, 1H), 7.94 (s, 1H), 8.53 (d, J = 8.3 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 28.6 (3C), 41.5, 42.9 (2C), 114.6, 117.7, 118.0, 124.7, 126.3, 126.4, 127.1, 135.8, 176.8. IR (neat) 1703, 1349, 1317, 1159 cm–1. MS (ESI) calcd for C15H20ClN2O5S2 [M + Cl]− 407.0508, found 407.0515.
4-Methyl-N-(5-methyl-1-pivaloyl-1H-indol-3-yl)-N-tosylbenzenesulfonamide (2g). White solid, mp 217.0–217.5 °C, 1H NMR (500 MHz, CDCl3) δ 1.39 (s, 9H), 2.28 (s, 3H), 2.47 (s, 6H), 6.71–6.73 (m, 1H), 7.12–7.16 (m, 1H), 7.32 (d, J = 8.2 Hz, 4H), 7.42 (s, 1H), 8.87 (d, J = 8.2 Hz, 4H), 8.31 (d, J = 8.6 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 21.2, 21.7 (2C), 28.5 (3C), 41.2, 115.6, 116.9, 118.4, 126.9, 127.4, 127.6, 128.7 (4C), 129.5 (4C), 133.8, 133.9, 136.3 (2C), 145.2 (2C), 176.6. IR (neat) 1701, 1379, 1353, 1308, 1156 cm–1. MS (ESI) calcd for C28H31N2O5S2 [M + H]+ 539.1669, found 539.1672.
N-(5-Fluoro-1-pivaloyl-1H-indol-3-yl)-4-methyl-N-tosylbenzenesulfonamide (2h). White solid, mp 214.5–215.2 °C, 1H NMR (500 MHz, CDCl3) δ 1.40 (s, 9H), 2.47 (s, 6H), 6.66 (dd, J = 8.5, 2.5 Hz, 1H), 7.05 (td, J = 9.0, 2.5 Hz, 1H), 7.33 (d, J = 8.5 Hz, 4H), 7.51 (s, 1H), 7.86 (d, J = 8.5 Hz, 4H), 8.43 (dd, J = 9.0, 4.5 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 21.7 (2C), 28.5 (3C), 41.3, 104.3 (d, JC–F = 25.0 Hz), 113.9 (d, JC–F = 25.0 Hz), 115.5 (d, JC–F = 3.5 Hz), 118.6 (d, JC–F = 9.5 Hz), 128.1 (d, JC–F = 9.5 Hz), 128.5 (4C), 129.0, 129.7 (4C), 131.9, 136.1 (2C), 145.5 (2C), 159.9 (d, JC–F = 240.8 Hz), 176.5. 19F NMR (471 MHz, CDCl3) δ −117.9. IR (neat) 1708, 1376, 1359, 1311, 1237, 1169 cm–1. MS (ESI) calcd for C27H28FN2O5S2 [M + H]+ 543.1418, found 543.1422.
N-(5-Bromo-1-pivaloyl-1H-indol-3-yl)-4-methyl-N-tosylbenzenesulfonamide (2i). White solid, mp 215.0–216.0 °C, 1H NMR (500 MHz, CDCl3) δ 1.41 (s, 9H), 2.48 (s, 6H), 6.09 (d, J = 1.8 Hz, 1H), 7.31–7.35 (m, 4H), 7.40 (dd, J = 9.0, 1.8 Hz, 1H), 7.51 (s, 1H), 7.82–7.86 (m, 4H), 8.32 (d, J = 9.0 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 21.7 (2C), 28.4 (3C), 41.3, 115.0, 117.7, 118.7, 121.3, 128.4, 128.50, 128.55 (4C), 128.8, 129.7 (4C), 134.3, 136.0 (2C), 145.6 (2C), 176.6. IR (neat) 1703, 1382, 1348, 1306, 1164, 659 cm–1. MS (ESI) calcd for C27H28BrN2O5S2 [M + H]+ 603.0618, found 603.0620.
N-(5-Methoxy-1-pivaloyl-1H-indol-3-yl)-4-methyl-N-tosylbenzenesulfonamide (2j). White solid, mp 220.0–221.0 °C, 1H NMR (500 MHz, CDCl3) δ 1.39 (s, 9H), 2.46 (s, 6H), 3.62 (s, 3H), 6.37 (d, J = 2.6 Hz, 1H), 6.92 (dd, J = 9.1, 2.6 Hz, 1H), 7.32 (d, J = 8.2 Hz, 4H), 7.43 (s, 1H), 7.88 (d, J = 8.2 Hz, 4H), 8.34 (d, J = 9.1 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 21.7 (2C), 28.6 (3C), 41.2, 55.2, 100.1, 115.4, 115.6, 118.3, 127.8, 128.0, 128.6 (4C), 129.6 (4C), 130.2, 136.4 (2C), 145.2 (2C), 156.7, 176.4. IR (neat) 1701, 1380, 1358, 1312, 1162, 1086 cm–1. MS (ESI) calcd for C28H31N2O6S2 [M + H]+ 555.1618, found 555.1621.
3-((4-Methyl-N-tosylphenyl)sulfonamido)-1-pivaloyl-1H-indol-5-yl pivalate (2k): White solid, mp 225.0 °C (dec.), 1H NMR (500 MHz, CDCl3) δ 1.35 (s, 9H), 1.40 (s, 9H), 2.45 (s, 6H), 6.64 (d, J = 2.5 Hz, 1H), 7.02 (dd, J = 9.0, 2.5 Hz, 1H), 7.33 (d, J = 8.3 Hz, 4H), 7.48 (s, 1H), 7.88 (d, J = 8.3 Hz, 4H), 8.46 (d, J = 9.0 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 21.7 (2C), 27.1 (3C), 28.5 (3C), 38.9, 41.3, 113.3, 115.7, 118.1, 120.0, 127.6, 128.58 (4C), 128.63, 129.7 (4C), 133.2, 136.2 (2C), 145.3 (2C), 147.7, 176.5, 176.8. IR (neat) 1750, 1708, 1377, 1358, 1311, 1167, 1119 cm–1. MS (ESI) calcd for C32H37N2O7S2 [M + H]+ 625.2037, found 625.2937.
Methyl 3-((4-methyl-N-tosylphenyl)sulfonamido)-1-pivaloyl-1H-indole-5-carboxylate (2l). White solid, mp 221.0–221.5 °C, 1H NMR (500 MHz, CDCl3) δ 1.41 (s, 9H), 2.46 (s, 6H), 3.89 (s, 3H), 7.33 (d, J = 8.3 Hz, 4H), 7.54 (s, 1H), 7.63 (d, J = 1.5 Hz, 1H), 7.86 (d, J = 8.3 Hz, 4H), 8.02 (d, J = 8.9, 1.5 Hz, 1H), 8.50 (d, J = 8.9 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 21.7 (2C), 28.4 (3C), 41.4, 52.0, 116.2, 117.1, 120.7, 126.1, 126.6, 127.2, 128.6 (4C), 128.8, 129.7 (4C), 136.0 (2C), 138.1, 145.5 (2C), 166.7, 176.7. IR (neat) 1717, 1379, 1360, 1313, 1165 cm–1. MS (ESI) calcd for C29H31N2O7S2 [M + H]+ 583.1567, found 583.1571.
N-(5-Cyano-1-pivaloyl-1H-indol-3-yl)-4-methyl-N-tosylbenzenesulfonamide (2m). White solid, mp 214.0–215.0 °C, 1H NMR (500 MHz, CDCl3) δ 1.42 (s, 9H), 2.49 (s, 6H), 7.17 (d, J = 1.5 Hz, 1H), 7.34 (d, J = 8.0 Hz, 4H), 7.55 (dd, J = 9.0, 1.5 Hz, 1H), 7.64 (s, 1H), 7.83 (d, J = 8.0 Hz, 4H), 8.55 (d, J = 8.5 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 21.7 (2C), 28.2 (3C), 41.5, 107.6, 115.5, 118.2, 118.8, 123.4, 126.9, 128.5 (4C), 128.7, 129.5, 129.8 (4C), 135.7 (2C), 137.2, 145.8 (2C), 176.6. IR (neat) 2221, 1715, 1363, 1348, 1308, 1169, 1086 cm–1. MS (ESI) calcd for C28H28N3O5S2 [M + H]+ 550.1465, found 550.1470.
N-(5-(1,3-Dioxoisoindolin-2-yl)-1-pivaloyl-1H-indol-3-yl)-4-methyl-N-tosylbenzenesulfonamide (2n). White solid, mp 227.5–228.0 °C, 1H NMR (500 MHz, CDCl3) δ 1.39 (s, 9H), 2.44 (s, 6H), 7.23 (d, J = 2.0 Hz, 1H), 7.38 (d, J = 8.3 Hz, 4H), 7.42 (dd, J = 9.0, 2.0 Hz, 1H), 7.47 (s, 1H), 7.80 (dd, J = 5.5, 3.0 Hz, 2H), 7.92 (d, J = 8.3 Hz, 4H), 7.96 (dd, J = 5.5, 3.0 Hz, 2H), 8.61 (d, J = 9.0 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 21.7 (2C), 28.4 (3C), 41.3, 115.6, 117.5, 118.0, 123.6 (2C), 124.7, 127.3, 127.9, 128.6 (4C), 128.9, 129.8 (4C), 131.8 (2C), 134.3 (2C), 134.9, 136.0 (2C), 145.3 (2C), 167.1 (2C), 176.6. IR (neat) 1727, 1705, 1375, 1355, 1308, 1167, 1080 cm–1. MS (ESI) calcd for C35H32N3O7S2 [M + H]+ 670.1676, found 670.1678.
4-Methyl-N-(6-methyl-1-pivaloyl-1H-indol-3-yl)-N-tosylbenzenesulfonamide (2o). White solid, mp 203.5–204.2 °C, 1H NMR (500 MHz, CDCl3) δ 1.38 (s, 9H), 2.45 (s, 3H), 2.46 (s, 6H), 6.95 (d, J = 8.0 Hz, 1H), 7.01 (d, J = 8.0 Hz, 1H), 7.29–7.35 (m, 4H), 7.37 (s, 1H), 7.84–7.89 (m, 4H), 8.32 (s, 1H). 13C NMR (125 MHz, CDCl3) δ 21.7 (2C), 21.9, 28.4 (3C), 41.3, 115.8, 117.4, 118.2, 124.6, 125.6, 127.0, 128.6 (4C), 129.6 (4C), 136.1, 136.26, 136.28 (2C), 145.2 (2C), 176.9. IR (neat) 1704, 1371, 1339, 1313, 1163 cm–1. MS (ESI) calcd for C28H30ClN2O5S2 [M + Cl]– 573.1290, found 573.1303.
N-(6-Fluoro-1-pivaloyl-1H-indol-3-yl)-4-methyl-N-tosylbenzenesulfonamide (2p). White solid, mp 215.0–215.5 °C, 1H NMR (500 MHz, CDCl3) δ 1.40 (s, 9H), 2.46 (s, 6H), 6.89–7.02 (m, 2H), 7.32 (d, J = 8.0 Hz, 4H), 7.46 (s, 1H), 7.85 (d, J = 8.0 Hz, 4H), 8.22 (dd, J = 10.3, 2.0 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 21.7 (2C), 28.4 (3C), 41.3, 104.7 (d, JC–F = 29.8 Hz), 112.6 (d, JC–F = 23.9 Hz), 115.7, 119.4 (d, JC–F = 9.5 Hz), 123.1, 127.8 (d, JC–F = 3.5 Hz), 128.5 (4C), 129.7 (4C), 135.7 (d, JC–F = 13.1 Hz), 136.1 (2C), 145.4 (2C), 161.7 (d, JC–F = 240.9 Hz), 176.6. 19F NMR (471 MHz, CDCl3) δ –115.1. IR (neat) 1707, 1382, 1345, 1315, 1230, 1162 cm–1. MS (ESI) calcd for C27H27ClFN2O5S2 [M + Cl]– 577.1039, found 577.1055.
N-(6-Chloro-1-pivaloyl-1H-indol-3-yl)-4-methyl-N-tosylbenzenesulfonamide (2q). White solid, mp 212.5–213.0 °C, 1H NMR (500 MHz, CDCl3) δ 1.40 (s, 9H), 2.47 (s, 6H), 6.94 (d, J = 8.6 Hz, 1H), 7.14 (dd, J = 8.6, 1.7 Hz, 1H), 7.30–7.35 (m, 4H), 7.46 (s, 1H), 7.82–7.87 (m, 4H), 8.54 (d, J = 1.7 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 21.7 (2C), 28.4 (3C), 41.3, 115.7, 117.6, 119.4, 124.8, 125.4, 128.1, 128.5 (4C), 129.7 (4C), 132.1, 135.8, 136.1 (2C), 145.4 (2C), 176.6. IR (neat) 1706, 1381, 1360, 1337, 1160, 1083 cm–1. MS (ESI) calcd for C27H28ClN2O5S2 [M + H]+ 559.1123, found 559.1123.
N-(6-Bromo-1-pivaloyl-1H-indol-3-yl)-4-methyl-N-tosylbenzenesulfonamide (2r). White solid, mp 214.0–214.8 °C, 1H NMR (500 MHz, CDCl3) δ 1.39 (s, 9H), 2.47 (s, 6H), 6.90 (d, J = 8.5 Hz, 1H), 7.29 (dd, J = 8.5, 1.5 Hz, 1H), 7.32 (d, J = 8.5 Hz, 4H), 7.44 (s, 1H), 7.85 (d, J = 8.5 Hz, 4H), 8.71 (d, J = 1.5 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 21.7 (2C), 28.3 (3C), 41.3, 115.7, 119.7, 119.9, 120.4, 125.7, 127.5, 128.0, 128.5 (4C), 129.7 (4C), 136.06 (2C), 136.11, 145.4 (2C), 176.6. IR (neat) 1705, 1380, 1336, 1308, 1159, 658 cm–1. MS (ESI) calcd for C27H27BrClN2O5S2 [M + Cl]– 637.0239, found 637.0256.
N-(6-Methoxy-1-pivaloyl-1H-indol-3-yl)-4-methyl-N-tosylbenzenesulfonamide (2s). White solid, mp 201.0–201.8 °C, 1H NMR (500 MHz, CDCl3) δ 1.40 (s, 9H), 2.46 (s, 6H), 3.86 (s, 3H), 6.80 (dd, J = 8.5, 2.3 Hz, 1H), 6.90 (d, J = 8.5 Hz, 1H), 7.29–7.34 (m, 4H), 7.36 (s, 1H), 7.84–7.89 (m, 4H), 8.07 (d, J = 2.3 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 21.7 (2C), 28.4 (3C), 41.3, 55.6, 100.8, 114.1, 115.9, 119.1, 120.5, 126.2, 128.5 (4C), 129.6 (4C), 136.3 (2C), 136.7, 145.2 (2C), 159.0, 177.1. IR (neat) 1703, 1378, 1346, 1312, 1286, 1162 cm–1. MS (ESI) calcd for C28H30ClN2O5S2 [M + Cl]– 589.1239, found 589.1257.
N-(4-Fluoro-1-pivaloyl-1H-indol-3-yl)-4-methyl-N-tosylbenzenesulfonamide (2t). White solid, mp 220.0–222.6 °C, 1H NMR (500 MHz, CDCl3) δ 1.42 (s, 9H), 2.46 (s, 6H), 6.85 (dd, J = 10.0, 8.0 Hz, 1H), 7.24–7.30 (m, 1H), 7.30–7.34 (m, 4H), 7.50 (s, 1H), 7.84–7.88 (m, 4H), 8.28 (d, J = 8.5 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 21.7 (2C), 28.4 (3C), 41.4, 110.2 (d, JC–F = 19.0 Hz), 112.9, 113.3 (d, JC–F = 3.6 Hz), 115.7 (d, JC–F = 17.9 Hz), 126.7 (d, JC–F = 7.3 Hz), 128.0, 128.6 (4C), 129.5 (4C), 136.1(2C), 137.7 (d, JC–F = 7.1 Hz), 145.1 (2C), 154.7 (d, JC–F = 249.1 Hz), 176.7. 19F NMR (471 MHz, CDCl3) δ –122.8. IR (neat) 1707, 1375, 1359, 1309, 1251, 1176 cm–1. MS (ESI) calcd for C27H27ClFN2O5S2 [M + Cl]– 577.1039, found 577.1053.
4-Methyl-N-(7-methyl-1-pivaloyl-1H-indol-3-yl)-N-tosylbenzenesulfonamide (2u). White solid, mp 190.0–191.0 °C, 1H NMR (500 MHz, CDCl3) δ 1.41 (s, 9H), 2.30 (s, 3H), 2.45 (s, 6H), 6.94 (dd, J = 7.5, 1.5 Hz, 1H), 7.06–7.12 (m, 2H), 7.20 (s, 1H), 7.29–7.33 (m, 4H), 7.84–7.89 (m, 4H). 13C NMR (125 MHz, CDCl3) δ 21.2, 21.7 (2C), 28.9 (3C), 42.1, 114.8, 116.6, 123.8, 125.4, 127.5, 128.00, 128.03, 128.6 (4C), 129.5 (4C), 134.9, 136.3 (2C), 145.1 (2C), 178.2. IR (neat) 1715, 1377, 1361, 1303, 1171 cm–1. MS (APCI) calcd for C28H31N2O5S2 [M + H]+ 539.1669, found 539.1670.
N-(5,6-Dichloro-1-pivaloyl-1H-indol-3-yl)-4-methyl-N-tosylbenzenesulfonamide (2v). White solid, mp 223.5–224.2 °C, 1H NMR (500 MHz, CDCl3) δ 1.41 (s, 9H), 2.48 (s, 6H), 6.87 (s, 1H), 7.32–7.36 (m, 4H), 7.52 (s, 1H), 7.82–7.86 (m, 4H), 8.65 (s, 1H). 13C NMR (125 MHz, CDCl3) δ 21.7 (2C), 28.3 (3C), 41.3, 115.0, 119.1, 119.5, 126.4, 128.5 (5C), 129.0, 129.8 (4C), 130.1, 134.0, 135.9 (2C), 145.7 (2C), 176.4. IR (neat) 1710, 1382, 1361, 1330, 1158, 1084 cm–1. MS (ESI) calcd for C27H27Cl2N2O5S2 [M + H]+ 593.0733, found 593.0732.
4-Methyl-N-(2-methyl-1-pivaloyl-1H-indol-3-yl)-N-tosylbenzenesulfonamide (2w). White solid, mp 158.0–159.0 °C, 1H NMR (500 MHz, CDCl3) δ 1.34 (s, 9H), 1.79 (s, 3H), 2.45 (s, 6H), 6.99–7.06 (m, 2H), 7.12–7.18 (m, 1H), 7.21 (d, J = 8.0 Hz, 1H), 7.30 (d, J = 8.5 Hz, 4H), 7.85 (d, J = 8.5 Hz, 4H). 13C NMR (125 MHz, CDCl3) δ 10.8, 21.6 (2C), 28.0 (3C), 44.4, 110.5, 111.7, 118.7, 121.7, 122.8, 125.8, 128.6 (4C), 129.5 (4C), 133.8, 136.7 (2C), 137.9, 145.0 (2C), 185.8. IR (neat) 1710, 1384, 1360, 1313, 1165, 1084 cm–1. MS (APCI) calcd for C28H31N2O5S2 [M + H]+ 539.1669, found 539.1671.
N-(1-Benzoyl-1H-indol-3-yl)-4-methyl-N-tosylbenzenesulfonamide (2x). White solid, mp 214.0–215.0 °C, 1H NMR (500 MHz, CDCl3) δ 2.47 (s, 6H), 7.10 (d, J = 8.0 Hz, 1H), 7.12 (s, 1H), 7.19–7.24 (m, 1H), 7.32 (d, J = 8.5 Hz, 4H), 7.36–7.41 (m, 1H), 7.45–7.51 (m, 2H), 7.59–7.65 (m, 3H), 7.87 (d, J = 8.5 Hz, 4H), 8.37 (d, J = 8.0 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 21.7 (2C), 116.2, 116.3, 119.0, 1124.5, 125.8, 128.0, 128.59 (4C), 128.64 (2C), 129.3, 129.4 (2C), 129.6 (4C), 132.5, 133.4, 135.0, 136.2 (2C), 145.2 (2C), 168.1. IR (neat) 1694, 1376, 1359, 1325, 1166 cm–1. MS (ESI) calcd for C29H25N2O5S2 [M + H]+ 545.1199, found 545.1205.
4-Methyl-N-tosyl-N-(1-tosyl-1H-indol-3-yl)benzenesulfonamide (2y). White solid, mp 182.0–183.0 °C, 1H NMR (500 MHz, CDCl3) δ 2.35 (s, 3H), 2.44 (s, 6H), 7.04 (d, J = 8.0 Hz, 1H), 7.08–7.13 (m, 1H), 7.23–7.30 (m, 7H), 7.43 (s, 1H), 7.70–7.77 (m, 6H), 7.92 (d, J = 8.5 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 21.5, 21.7 (2C), 113.5, 116.8, 119.4, 123.9, 125.4, 126.9 (2C), 128.2, 128.3, 128.5 (4C), 129.5 (4C), 130.0 (2C), 133.7, 134.5, 136.0 (2C), 145.3 (2C), 145.5. IR (neat) 1595, 1372, 1355, 1283, 1168, 1086 cm–1. MS (ESI) calcd for C29H27N2O6S3 [M + H]+ 595.1026, found 595.1027.

4. Conclusions

In conclusion, we developed a 3-amination of indole derivatives using a hypervalent iodine(III) compound that promotes the formation of indolyl(aryl)iodonium imides. This reaction was followed by a copper-catalyzed oxidative C–N coupling reaction to obtain the 3-amino indole derivatives regioselectively. The o-alkoxy groups on (diacetoxy)iodoarenes resulted in higher reactivity than the o-alkyl groups in the formation of indolyl(aryl)iodonium imides (first step). In addition, the 3-amino indole derivatives were given as a single isomer product by a decomposition of 2-amino indole derivatives under copper-catalyzed reaction conditions (second step). The design of substituted iodoarene as a high-performance hypervalent iodine compounds and the combined use of hypervalent iodine compound and a transition-metal catalyst for the unique transformation are underway in our laboratory.

Supplementary Materials

The following are available online. The 1H and 13C NMR spectra of compounds in 3-amination of indole derivatives, and crystal data of 2a can be found in the Supporting Information.

Author Contributions

Conceptualization, K.M.; Methodology, K.M.; Validation, K.M; Investigation and Analyses, K.W. and K.M.; Writing—original draft preparation, K.M.; Writing—review and editing, K.M.; Visualization, K.M.; Supervision, K.M.; Project Administration, K.M.; Funding Acquisition, K.M.

Funding

Financial support in the form of a Grant-in-Aid for Scientific Research (No. G15K17819) from the Ministry of Education, Culture, Sports, Science and Technology in Japan is gratefully acknowledged.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Arzel, E.; Rocca, P.; Grellier, P.; Labaeïd, M.; Frappier, F.; Guéritte, F.; Gaspard, C.; Marsais, F.; Godard, A.; Quéguiner, G. New Synthesis of Benzo-δ-carbolines, Cryptolepines, and Their Salts: In Vitro Cytotoxic, Antiplasmodial, and Antitrypanosomal Activities of δ-Carbolines, Benzo-δ-carbolines, and Cryptolepines. J. Med. Chem. 2001, 44, 949–960. [Google Scholar] [CrossRef] [PubMed]
  2. Kumar, A.; Sharma, S.; Bajaj, K.; Sharma, S.; Panwar, H.; Singh, T.; Srivastava, V.K. Some new 2,3,6-trisubstituted quinazolinones as potent anti-inflammatory, analgesic and COX-II inhibitors. Bioorg. Med. Chem. 2003, 11, 5293–5299. [Google Scholar] [CrossRef]
  3. Bahekar, R.H.; Jain, M.R.; Goel, A.; Patel, D.N.; Prajapati, V.M.; Gupta, A.A.; Jadav, P.A.; Patel, P.R. Design, synthesis, and biological evaluation of substituted-N-(thieno[2,3-b]pyridin-3-yl)-guanidines, N-(1H-pyrrolo[2,3-b]pyridin-3-yl)-guanidines, and N-(1H-indol-3-yl)-guanidines. Bioorg. Med. Chem. 2007, 15, 3248–3265. [Google Scholar] [CrossRef] [PubMed]
  4. Romagnoli, R.; Baraldi, P.G.; Sarkar, T.; Carrion, M.D.; Cara, C.L.; Cruz-Lopez, O.; Preti, D.; Tabrizi, M.A.; Tolomeo, M.; Grimaudo, S.; et al. Synthesis and Biological Evaluation of 1-Methyl-2-(3′,4′,5′-trimethoxybenzoyl)-3-aminoindoles as a New Class of Antimitotic Agents and Tubulin Inhibitors. J. Med. Chem. 2008, 51, 1464–1468. [Google Scholar] [CrossRef] [PubMed]
  5. Pews-Davtyan, A.; Tillack, A.; Schmöle, A.-C.; Ortinau, S.; Frech, M.J.; Rolfs, A.; Beller, M. A new facile synthesis of 3-amidoindole derivatives and their evaluation as potential GSK-3β inhibitors. Org. Biomol. Chem. 2010, 8, 1149–1153. [Google Scholar] [CrossRef] [PubMed]
  6. Nirogi, R.V.S.; Deshpande, A.D.; Kambhampati, R.; Badange, R.K.; Kota, L.; Daulatabad, A.V.; Shinde, A.K.; Ahmad, I.; Kandikere, V.; Jayarajan, P.; et al. Indole-3-piperazinyl derivatives: Novel chemical class of 5-HT6 receptor antagonists. Bioorg. Med. Chem. Lett. 2011, 21, 346–349. [Google Scholar] [CrossRef] [PubMed]
  7. Roue, N.; Delahaigue, T.; Barret, R. Efficient mononitration of indolic compounds with nitric acid impregnated on silica gel. Heterocycles 1996, 43, 263–266. [Google Scholar]
  8. Pelkey, E.T.; Gribble, G.W. Synthesis and reaction of N-protected 3-nitroindoles. Synthesis 1999, 1999, 1117–1122. [Google Scholar] [CrossRef]
  9. Nowrouzi, N.; Zareh Jonaghani, M. Nitration of aromatic compounds under neutral conditions using the Ph2PCl/I2/AgNO3 reagent system. Tethahedron Lett. 2011, 52, 5081–5082. [Google Scholar] [CrossRef]
  10. Nowrouzi, N.; Mehranpour, A.M.; Bashiri, E.; Shayan, Z. Aromatic nitration under neutral conditions using N-bromosuccinimide/silver(I) nitrate. Tetrahedron Lett. 2012, 53, 4841–4842. [Google Scholar] [CrossRef]
  11. Azadi, R.; Nazari-Far, Z. N-Methyl-2-chloropyridinium iodide/NaNO2/Wet SiO2: Neutral reagent system for the nitration of activated aromatic compounds under very mild conditions. Lett. Org. Chem. 2015, 12, 136–140. [Google Scholar] [CrossRef]
  12. Kumar, M.S.; Sriram, Y.H.; Venkateswarlu, M.; Rajanna, K.C.; Sudhakar, M.S.; Venkanna, P.; Saiprakash, P.K. Silica-supported perchloric acid and potassium bisulfate as reusable green catalysts for nitration of aromatics under solvent-free microwave conditions. Synth. Commun. 2018, 48, 59–67. [Google Scholar] [CrossRef]
  13. Parasad, P.K.; Kalshetti, R.G.; Reddi, R.N.; Kamble, S.P.; Sudalai, A. I2-mediated regioselective C-3 azidation of indoles. Org. Biomol. Chem. 2016, 14, 3027–3030. [Google Scholar] [CrossRef] [PubMed]
  14. Ortiz, G.X., Jr.; Hemric, B.N.; Wang, Q. Direct and Selective 3-Amidation of Indoles Using Electrophilic N-[(Benzenesulfonyl)oxy]-amides. Org. Lett. 2017, 19, 1314–1317. [Google Scholar] [CrossRef] [PubMed]
  15. Lubriks, D.; Sokolovs, I.; Suna, E. Indirect C–H Azidation of Heterocycles via Copper-Catalyzed Regioselective Fragmentation of Unsymmetrical λ3-Iodanes. J. Am. Chem. Soc. 2012, 134, 15436–15442. [Google Scholar] [CrossRef] [PubMed]
  16. Sokolovs, I.; Lubriks, D.; Suna, E. Copper-Catalyzed Intermolecular C–H Amination of (Hetero)arenes via Transient Unsymmetrical λ3-Iodanes. J. Am. Chem. Soc. 2014, 136, 6920–6928. [Google Scholar] [CrossRef] [PubMed]
  17. Liu, H.-H.; Wang, Y.; Deng, G.; Yang, L. Transition Metal-Free Regioselective C–3 Amidation of Indoles with N-Fluorobenzenesul-fonimide. Adv. Synth. Catal. 2013, 355, 3369–3374. [Google Scholar] [CrossRef]
  18. Moriyama, K.; Ishida, K.; Togo, H. Regioselective Csp2–H dual functionalizationof indoles using hypervalent iodine(III):bromo-amination via 1,3-migration of imides on indolyl(phenyl)iodonium imides. Chem. Commun. 2015, 51, 2273–2276. [Google Scholar]
  19. Ishida, K.; Togo., H.; Moriyama, K. Preparation of Heteroaromatic (Aryl)iodonium Imides as I–N Bond-Containing Hypervalent Iodine. Chem. Asian J. 2016, 11, 3583–3588. [Google Scholar] [CrossRef] [PubMed]
  20. Moriyama, K.; Hamada, T.; Ishida, K.; Togo, H. 1,3-Iodo-Amination of 2-Methyl Indoles via Csp2–Csp3 Dual Functionalization with Iodine Reagent. Chem. Commun. 2018, 54, 4258–4261. [Google Scholar] [CrossRef]
  21. Watanabe, K.; Moriyama, K. Copper-Catalyzed Indole-Selective C–N Coupling Reaction of Indolyl(2-alkoxy-phenyl)iodonium Imides; Effect of Substituent on Iodoarene as Dummy Ligand. J. Org. Chem. 2018, 83, 14827–14833. [Google Scholar] [CrossRef] [PubMed]
Sample Availability: Samples of the compounds are not available from the authors.
Molecules 24 01147 sch001 550
Scheme 1. 3-Installation of amino group into indole skeleton. (A) Nitration. 3-Amination of electron-donating group protected indoles: (B) Azidation, (C) Electrophilic amidation, (D) Azidation via formation of indolyl(phenyl)iodonium azide, (E) Amidation via formation of indolyl(Mes)iodonium tosylate. 3-Amination of electron-withdrawing group protected indoles: (F) Electrophilic amidation, (G) Amidation via formation of indolyl(aryl)iodonium imide.
Scheme 1. 3-Installation of amino group into indole skeleton. (A) Nitration. 3-Amination of electron-donating group protected indoles: (B) Azidation, (C) Electrophilic amidation, (D) Azidation via formation of indolyl(phenyl)iodonium azide, (E) Amidation via formation of indolyl(Mes)iodonium tosylate. 3-Amination of electron-withdrawing group protected indoles: (F) Electrophilic amidation, (G) Amidation via formation of indolyl(aryl)iodonium imide.
Molecules 24 01147 sch001
Molecules 24 01147 sch002 550
Scheme 2. Effect of substituent on iodoarene in copper-catalyzed C–N coupling reaction of indolyl(aryl)iodonium imides.
Scheme 2. Effect of substituent on iodoarene in copper-catalyzed C–N coupling reaction of indolyl(aryl)iodonium imides.
Molecules 24 01147 sch002
Molecules 24 01147 sch003 550
Scheme 3. Copper-catalyzed 3-amination of 1b with o-substituted (diacetoxyiodo)arenes. a Numbers in parentheses indicate yield of N-pivaloyl-2-bistosylimdo-5-chloroindole (3b).
Scheme 3. Copper-catalyzed 3-amination of 1b with o-substituted (diacetoxyiodo)arenes. a Numbers in parentheses indicate yield of N-pivaloyl-2-bistosylimdo-5-chloroindole (3b).
Molecules 24 01147 sch003
Molecules 24 01147 sch004 550
Scheme 4. Copper-catalyzed 3-amination of N-protected indoles (1). a Numbers in parentheses indicate yield of N-pivaloyl-2-bismesylimdo-chloroindole (3f). b For 24 h (in the first step). c At 100 °C (in the second step).
Scheme 4. Copper-catalyzed 3-amination of N-protected indoles (1). a Numbers in parentheses indicate yield of N-pivaloyl-2-bismesylimdo-chloroindole (3f). b For 24 h (in the first step). c At 100 °C (in the second step).
Molecules 24 01147 sch004
Molecules 24 01147 sch005 550
Scheme 5. Comparison of (diacetoxyiodo)arenes in the formation of indolyl(aryl)iodonium imide.
Scheme 5. Comparison of (diacetoxyiodo)arenes in the formation of indolyl(aryl)iodonium imide.
Molecules 24 01147 sch005
Molecules 24 01147 sch006 550
Scheme 6. Reaction of 2-amino indole derivatives (3b) in the presence of copper-catalyst.
Scheme 6. Reaction of 2-amino indole derivatives (3b) in the presence of copper-catalyst.
Molecules 24 01147 sch006
Molecules 24 01147 sch007 550
Scheme 7. Plausible reaction mechanism for 3-amination of indole derivatives.
Scheme 7. Plausible reaction mechanism for 3-amination of indole derivatives.
Molecules 24 01147 sch007
Table
Table 1. Screening for ArI(OAc)2 and solvent for 3-amination of indole (1a).
Table 1. Screening for ArI(OAc)2 and solvent for 3-amination of indole (1a).
Molecules 24 01147 i001
EntryArI(OAc)2Temp. 1 (°C)SolventTemp. 2 (°C)Yield (%)
1PhI(OAc)240TolueneReflux26 (58) a
2A40TolueneReflux76
3B60TolueneReflux82
4C60TolueneReflux55 (19) b
5D60TolueneReflux81
6E60TolueneReflux2 (76) b
7A40Xylene13078
8B60Xylene13076
9D60Xylene13078
10 cA40Xylene13016 (67) d
11 cB60Xylene13042 (9) d
12 cD60Xylene13032 (64) d
a Number in parentheses indicates yield of N,N-bistosylaniline. b Numbers in parentheses indicate recovery of 1a. c The reaction was carried out in the absence of Cu(MeCN)4BF4. d Numbers in parentheses indicate yield of indolyl(aryl)iodonium imide (4).

Share and Cite

MDPI and ACS Style

Watanabe, K.; Moriyama, K. Cu-Catalyzed Oxidative 3-Amination of Indoles via Formation of Indolyl(aryl)iodonium Imides Using o-Substituted (Diacetoxyiodo)arene as a High-Performance Hypervalent Iodine Compound. Molecules 2019, 24, 1147. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules24061147

AMA Style

Watanabe K, Moriyama K. Cu-Catalyzed Oxidative 3-Amination of Indoles via Formation of Indolyl(aryl)iodonium Imides Using o-Substituted (Diacetoxyiodo)arene as a High-Performance Hypervalent Iodine Compound. Molecules. 2019; 24(6):1147. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules24061147

Chicago/Turabian Style

Watanabe, Kazuhiro, and Katsuhiko Moriyama. 2019. "Cu-Catalyzed Oxidative 3-Amination of Indoles via Formation of Indolyl(aryl)iodonium Imides Using o-Substituted (Diacetoxyiodo)arene as a High-Performance Hypervalent Iodine Compound" Molecules 24, no. 6: 1147. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules24061147

Article Metrics

Back to TopTop